What do we know about Type 2 chronic inflammatory diseases like asthma, atopic dermatitis, chronic urticaria, allergic rhinitis and eosinophilic gastrointestinal disorders? It's all here in a new Nature Reviews Drug Discovery review nature.com/articles/s4157… rdcu.be/difAc Pavel Kolkhir

The #UDAY2023 website is now live! Visit urticariaday.org to find out more about this year's campaign, download all the new resources, add your #UrticariaDay2023 event and start promoting and raising awareness for #Urticaria!

Living with #Urticaria can be incredibly challenging. It is crucial that everyone affected by this condition has equal access to the care they need to manage their symptoms and improve their quality of life. Find out more: urticariaday.org #UrticariaDay2023 #UDAY2023

Martin Metz from the Institute of Allergology, Charité-Universitätsmedizin Berlin, Germany, presents their Review Article published in #Allergy: Metz, M, Kolkhir, P, Altrichter, S, et al. Mast cell silencing: A novel therapeutic approach for #urticaria and other mast

Open Access: Mast cell silencing: A novel therapeutic approach for urticaria and other mast cell-mediated diseases First author: Martin Metz; corresponding author: Marcus Maurer doi.org/10.1111/all.15… This is a review article with 145 references and 4 figures on chronic

Following a coffee break, we had the opportunity to listen to the Dermatology Section chair, José Luís Garcia, and learned about "Standard baselines of worldwide #PatchTests: similarities and differences", also Pavel Kolkhir about "#UrticarialVasculitis". #SAC2023

1st of October is the Uday -Urticaria awareness day- This disease is more than an itch, it really disturbs patients’ lives. We are working in General Assembly²LEN e.V. Dorothy Taylor and Aalim Care centers to make life easier for our patients. Please visit the webpage 👉🏻 urticariaday.org

Urticaria session at the #EADV2023 inducible urticarias, biomarkers for chronic urticaria, future drugs for urticaria and angioedema management were all covered by Mojca Bizjak Pavel Kolkhir , clive Grattan. Lots of new information out there! #urticaria

#chronicurticaria

The European Network for IgE-Mediated Autoimmunity and Autoallergy (ENIGMA) initiative. Correspondence from Pavel Kolkhir, Marcus Maurer and colleagues nature.com/articles/s4159…

Chronic urticaria is a common and debilitating skin disease. A new Therapeutics article focuses on the evidence for novel drugs and their role in addressing an unmet need for personalised management of patients with chronic urticaria: hubs.ly/Q02GlB_L0

Open Access: An algorithm for the diagnosis and treatment of chronic inducible urticaria, 2024 update. Corresponding author: Marcus Maurer Read the article here: doi.org/10.1111/all.16… Maurer et al. present an updated medical algorithm for the diagnosis and treatment of

Open Access: Disease modification in chronic spontaneous urticaria. Corresponding author: Marcus Maurer Read the article here: doi.org/10.1111/all.16… With over 120 references and 8 figures this review articles on recent developments of disease-modifying treatment for chronic

Living with #Urticaria can be tough, but with guidance from healthcare professionals, you can manage it effectively. Dermatologists or immunologists can diagnose and offer treatments to alleviate symptoms. urticariaday.org #UrticariaDay2024 #UDAY2024 #udaymyjourney

This Review on chronic spontaneous urticaria summarizes current evidence on epidemiology, pathophysiology, diagnosis, and treatment. ja.ma/3BhpqV7

Author Pavel Kolkhir discusses the current evidence on the epidemiology, pathophysiology, diagnosis, and treatment of chronic spontaneous urticaria with JAMA Senior Editor Karen Lasser. ja.ma/3ZzBpYl

It's #UrticariaDay2024 and the theme is Your Journey! Each experience with #Urticaria is unique. Whether patient, caregiver, healthcare professional, or advocate, your journey inspires. Join us in spreading awareness and support: urticariaday.org #UDAY2024

📢One of the most appreciated/liked articles in the social media of Allergy published in 2023: Marcus Maurer from the Institute for Allergology, Charité – Universitätsmedizin Berlin, Germany, presents their research findings published in Allergy: Su, H., Kolkhir, P., Scheffel,

Mortality rates among patients with chronic spontaneous #urticaria were more pronounced among patients who were white and who were aged 18 to 40 years, said Pavel Kolkhir of Charité - Universitätsmedizin Berlin. Also, Dr. Thomas B. Casale of USF Health shares his Perspective. healio.com/news/allergy-a…

Allergy vs. Pseudoallergy vs. Autoallergy: get an update about the differences! Crucial for drug reactions & skin diseases. Pavel Kolkhir explains it all. Pavel Kolkhir #BSACI2025